Merck Sharp + Dohme Corp.

Joann Bohn

Amjad Ali

Peter J Sinclair

Zhijian Lu

Christopher Francis Thompson

Qiaolin Deng

Gayle E Taylor

Nazia Quraishi

Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula 1, Aand A2 are each an aromatic ring, a 5-6-membered heterocyclic ring, an aromatic ring fused to a heterocyclic ring, a phenyl ring fused to a heterocyclic ring, or a cycloalkyl ring. 

CETP inhibitors

Growing community of inventors

North Plainfield, NJ, United States of America

Joann Bohn